Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1228

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 4
Chunk 1228
---
�
    For
    as long as Ms. Kampf serves as a member of the Compensation Committee, Ms. Kampf will be paid $5,000 annually to be paid $1,250 each
    calendar quarter, with the amount for any partial calendar quarter being appropriately prorated.

    ○
    For
    as long as Ms. Kampf serves as Chairman of the Nominating Committee, Ms. Kampf will be $7,500 annually to be paid $1,875 each calendar
    quarter, with the amount for any partial calendar quarter being appropriately prorated.

    ●
    Mr.
    Hemmerly:

    ○
    For
    as long as Mr. Hemmerly serves as a member of the Audit Committee, Mr. Hemmerly will be paid $5,000 annually to be paid $1,250 each
    calendar quarter, with the amount for any partial calendar quarter being appropriately prorated.

    ○
    For
    as long as Mr. Hemmerly serves as Chairman of the Compensation Committee, Mr. Hemmerly will be $10,000 annually to be paid $2,500
    each calendar quarter, with the amount for any partial calendar quarter being appropriately prorated.

    ○
    For
    as long as Mr. Hemmerly serves as a member of the Nominating Committee, Mr. Hemmerly will be paid $4,000 annually to be paid $1,000
    each calendar quarter, with the amount for any partial calendar quarter being appropriately prorated.

Each
of the agreements contains customary confidentiality provisions, and customary provisions relating to intellectual property created by
the executive (i.e., a “work-made-for-hire” provision. Each of the agreements is governed by Delaware law and contains customary
representations and warranties and other miscellaneous provisions.

ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The
following table sets forth information regarding the beneficial ownership of our common stock as of March 12, 2025 by:

    ●
    each
    person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;

    ●
    each
    of our executive officers and directors that beneficially owns shares of our common stock; and

    ●
    all
    our executive officers and directors as a group.

In